Biohaven (BHVN) announced the pricing of underwritten public offering of 5,263,158 of its common shares at a price to the public of $47.50 per share. Biohaven has granted the underwriters a 30-day option to purchase up to an additional 789,473 common shares at the public offering price, less underwriting discounts and commissions.
The gross proceeds from the offering are expected to be approximately $250 million. The offering is expected to close on October 2, 2024. Biohaven plans to use the net proceeds for general corporate purposes.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.